Peaucelle, A.-S. et al. 2023. An Unusual Skin Adverse Event after Switching from Intravenous to Subcutaneous VEDOLIZUMAB Therapy in Patients with Ulcerative Colitis. Archives of Clinical and Medical Case Reports. 7, 1 (Feb. 2023), 77–79.